2017 Edition of IAM Patent 1000 Recognizes Wolf Greenfield
Wolf Greenfield has been recognized in IAM Patent 1000 2017 – The World’s Leading Patent Professionals. The firm was highly recommended for patent prosecution, recommended for transactions, and listed in the bronze category for litigation. In addition, nine Wolf Greenfield attorneys were recognized individually.
Nominate Our Post-Grant Blog for the ABA Journal's List of Best Legal Blogs!
Are you a fan of The Post-Grant Stategist? Then we hope you'll consider nominating us for the ABA Journal's 11th annual Blawg 100. The Blawg 100 celebrates the best legal blogs, and the ABA wants input from "amici" like you on which blogs to include on the list. The nomination form is quick and easy. We would greatly appreciate your support!
IP Alert: Supreme Court Dictates How Long Biosimilar Applicants Must Wait Before Bringing Approved Products to Market
Last month, the Supreme Court issued a rulling in Sandoz Inc. v Amgen Inc., answering two fiercely disputed questions about how certain rules set forth under 42 U.S.C. § 262 should be interpreted.
Invention Details Need Not Be Public
Mike PomianekandMichelle Nyeinexplore the recent Helsinn Healthcare v Teva Pharmaceuticals Federal Circuit decision and answer the question: do 'secret' sales trigger the on-sale bar after the America Invents Act?
Wolf Greenfield's Client Portal Webinar
Please join us for an online demonstration of the Wolf Greenfield Client Portal on Tuesday, July 18 from 12:00-12:40pm EDT. We’ll show you how easy it is to access the portal, dive into its features and help you start saving time with this tool.
Estop Confusing Us: District Courts Take Wildly Different Views on IPR Estoppel
This email contains Attorney Advertising. Prior results do not guarantee a similar outcome. You received this email because you are subscribed to Newsletter from Wolf, Greenfield & Sacks, P.C. If you prefer not to receive emails from Wolf, Greenfield & Sacks, P.C. you may unsubscribe or set your email preferences.
